Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA's ODAC recommends approval of Mylotarg for relapsed AML

March 21, 2000

Picower Institute presents new immunotherapeutic anticancer agents

March 17, 2000

Antisoma takes up another product from ICRF for clinical development

March 17, 2000

Low-dose M-Vax shows promise in stage III metastatic melanoma

March 17, 2000

Seattle Genetics updates MAb program

March 17, 2000

IND filed by NeoPharm for glioblastoma treatment

March 16, 2000

OvaRex shows evidence of cellular immune response

March 14, 2000

The FDA approves Pacis immunotherapy for treatment of bladder cancer

March 13, 2000

SciClone's Zadaxin boosts immune recognition of tumor cells

March 8, 2000

Antigenic telomerase-derived proteins/peptides for cancer

March 6, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...